Want to join the conversation?
$AMRI and Icagen announced they have signed a 3-year collaboration agreement to co-market Icagen's ion channel and transporter technology to global pharmaceutical and biotechnology clients. $AMRI clients and customers gain access to Icagen's broad portfolio of assay tools and technologies for ion channel and transporter research.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.